This report provides a comprehensive analysis of the global intrasaccular embolic coils market, which is projected to experience steady growth through 2032. These minimally invasive medical devices are essential for treating cerebral aneurysms via endovascular coiling. The study examines market dynamics, segmentation by type and application, and regional trends across the Americas, APAC, and Europe. Additionally, it evaluates the competitive landscape, profiling key industry players and their strategic positions to identify emerging opportunities within the sector.

Market Overview

Global Market Projections

The global Intrasaccular Embolic Coils market is projected to grow from US$ 1559 million in 2025 to US$ 2474 million in 2032, representing a compound annual growth rate (CAGR) of 7.0% from 2026 to 2032.

Regional Market Projections

• United States: The market for Intrasaccular Embolic Coils in the United States is expected to experience growth from 2025 through 2032.
• China: The market for Intrasaccular Embolic Coils in China is expected to experience growth from 2025 through 2032.
• Europe: The market for Intrasaccular Embolic Coils in Europe is expected to experience growth from 2025 through 2032.

Product Description & Clinical Application

Intrasaccular embolic coils are medical devices used to treat cerebral aneurysms by filling and occluding the aneurysm sac. The clinical process involves the following:

• Procedure: These coils are inserted into the aneurysm via a catheter threaded through the blood vessels, typically accessed through the femoral artery.
• Mechanism of Action: Once positioned inside the aneurysm, the coils are deployed to create a dense meshwork that promotes blood clotting within the sac, effectively sealing it off from the rest of the circulatory system.
• Clinical Benefit: This procedure, known as endovascular coiling, helps prevent the aneurysm from rupturing, thereby reducing the risk of hemorrhagic stroke.
• Classification: Intrasaccular embolic coils serve as a minimally invasive and highly effective treatment option for patients with cerebral aneurysms.

Market Segmentation

By Type

• Bare Platinum Coils
• Hydrogel Coils
• Other

By Application

• Hospital
• Ambulatory Surgery Centres
• Other

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on primary expert input and analysis of their coverage, product portfolios, and market penetration:

• MicroVention, Inc.
• Medtronic Plc.
• Stryker Corporation
• Cook Medical
• dePuySynthes
• Kaneka Pharmaceuticals
• Penubbra
• Braile Biomedica

Market Concentration

Global key players include MicroVention, Inc., Medtronic Plc., Stryker Corporation, Cook Medical, and dePuySynthes. In terms of revenue, the two largest global companies occupied a significant share of the market in 2025.

About the Research Report

Report Scope and Methodology

LP Information, Inc. (LPI)'s newest research report, the “Intrasaccular Embolic Coils Industry Forecast,” provides a comprehensive analysis of the global Intrasaccular Embolic Coils landscape. The report:

• Reviews total world Intrasaccular Embolic Coils sales in 2025.
• Provides a detailed analysis in US$ millions of the world Intrasaccular Embolic Coils industry.
• Offers a comprehensive analysis by region and market sector of projected sales for 2026 through 2032, including breakdowns by region, market sector, and sub-sector.
• Utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to provide a nuanced view of the current state and future trajectory of the industry.

Key Insights and Analysis Areas

This Insight Report highlights key trends and evaluates the following:

• Market Dynamics: Product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
• Strategic Analysis: Leading global companies' strategies, including Intrasaccular Embolic Coils portfolios and capabilities, market entry strategies, market positions, and geographic footprints.
• Growth Drivers: Key market trends, drivers, and affecting factors shaping the global outlook.
• Opportunity Identification: Forecasts broken down by Type, Application, geography, and market size to highlight emerging pockets of opportunity.

Key Questions Addressed

• What is the 10-year outlook for the global Intrasaccular Embolic Coils market?
• What factors are driving Intrasaccular Embolic Coils market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Intrasaccular Embolic Coils market opportunities vary by end market size?
• How does Intrasaccular Embolic Coils break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Intrasaccular Embolic Coils Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Intrasaccular Embolic Coils by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Intrasaccular Embolic Coils by Country/Region, 2021, 2025 & 2032

  • 2.2 Intrasaccular Embolic Coils Segment by Type

    • 2.2.1 Bare Platinum Coils

    • 2.2.2 Hydrogel Coils

    • 2.2.3 Other

    • 2.2.4 Intrasaccular Embolic Coils Sales by Type

      • 2.2.4.1 Global Intrasaccular Embolic Coils Sales Market Share by Type (2021-2026)
      • 2.2.4.2 Global Intrasaccular Embolic Coils Revenue and Market Share by Type (2021-2026)
      • 2.2.4.3 Global Intrasaccular Embolic Coils Sale Price by Type (2021-2026)

  • 2.3 Intrasaccular Embolic Coils Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Ambulatory Surgery Centres

    • 2.3.3 Other

    • 2.3.4 Intrasaccular Embolic Coils Sales by Application

      • 2.3.4.1 Global Intrasaccular Embolic Coils Sale Market Share by Application (2021-2026)
      • 2.3.4.2 Global Intrasaccular Embolic Coils Revenue and Market Share by Application (2021-2026)
      • 2.3.4.3 Global Intrasaccular Embolic Coils Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Intrasaccular Embolic Coils Breakdown Data by Company

    • 3.1.1 Global Intrasaccular Embolic Coils Annual Sales by Company (2021-2026)

    • 3.1.2 Global Intrasaccular Embolic Coils Sales Market Share by Company (2021-2026)

  • 3.2 Global Intrasaccular Embolic Coils Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Intrasaccular Embolic Coils Revenue by Company (2021-2026)

    • 3.2.2 Global Intrasaccular Embolic Coils Revenue Market Share by Company (2021-2026)

  • 3.3 Global Intrasaccular Embolic Coils Sale Price by Company

  • 3.4 Key Manufacturers Intrasaccular Embolic Coils Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Intrasaccular Embolic Coils Product Location Distribution

    • 3.4.2 Players Intrasaccular Embolic Coils Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Intrasaccular Embolic Coils by Geographic Region

  • 4.1 World Historic Intrasaccular Embolic Coils Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Intrasaccular Embolic Coils Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Intrasaccular Embolic Coils Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Intrasaccular Embolic Coils Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Intrasaccular Embolic Coils Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Intrasaccular Embolic Coils Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Intrasaccular Embolic Coils Sales Growth

  • 4.4 APAC Intrasaccular Embolic Coils Sales Growth

  • 4.5 Europe Intrasaccular Embolic Coils Sales Growth

  • 4.6 Middle East & Africa Intrasaccular Embolic Coils Sales Growth

• 5 Americas

  • 5.1 Americas Intrasaccular Embolic Coils Sales by Country

    • 5.1.1 Americas Intrasaccular Embolic Coils Sales by Country (2021-2026)

    • 5.1.2 Americas Intrasaccular Embolic Coils Revenue by Country (2021-2026)

  • 5.2 Americas Intrasaccular Embolic Coils Sales by Type (2021-2026)

  • 5.3 Americas Intrasaccular Embolic Coils Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Intrasaccular Embolic Coils Sales by Region

    • 6.1.1 APAC Intrasaccular Embolic Coils Sales by Region (2021-2026)

    • 6.1.2 APAC Intrasaccular Embolic Coils Revenue by Region (2021-2026)

  • 6.2 APAC Intrasaccular Embolic Coils Sales by Type (2021-2026)

  • 6.3 APAC Intrasaccular Embolic Coils Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Intrasaccular Embolic Coils by Country

    • 7.1.1 Europe Intrasaccular Embolic Coils Sales by Country (2021-2026)

    • 7.1.2 Europe Intrasaccular Embolic Coils Revenue by Country (2021-2026)

  • 7.2 Europe Intrasaccular Embolic Coils Sales by Type (2021-2026)

  • 7.3 Europe Intrasaccular Embolic Coils Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Intrasaccular Embolic Coils by Country

    • 8.1.1 Middle East & Africa Intrasaccular Embolic Coils Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Intrasaccular Embolic Coils Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Intrasaccular Embolic Coils Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Intrasaccular Embolic Coils Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Intrasaccular Embolic Coils

  • 10.3 Manufacturing Process Analysis of Intrasaccular Embolic Coils

  • 10.4 Industry Chain Structure of Intrasaccular Embolic Coils

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Intrasaccular Embolic Coils Distributors

  • 11.3 Intrasaccular Embolic Coils Customer

• 12 World Forecast Review for Intrasaccular Embolic Coils by Geographic Region

  • 12.1 Global Intrasaccular Embolic Coils Market Size Forecast by Region

    • 12.1.1 Global Intrasaccular Embolic Coils Forecast by Region (2027-2032)

    • 12.1.2 Global Intrasaccular Embolic Coils Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Intrasaccular Embolic Coils Forecast by Type (2027-2032)

  • 12.7 Global Intrasaccular Embolic Coils Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 MicroVention, Inc.

    • 13.1.1 MicroVention, Inc. Company Information

    • 13.1.2 MicroVention, Inc. Intrasaccular Embolic Coils Product Portfolios and Specifications

    • 13.1.3 MicroVention, Inc. Intrasaccular Embolic Coils Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 MicroVention, Inc. Main Business Overview

    • 13.1.5 MicroVention, Inc. Latest Developments

  • 13.2 Medtronic Plc.

    • 13.2.1 Medtronic Plc. Company Information

    • 13.2.2 Medtronic Plc. Intrasaccular Embolic Coils Product Portfolios and Specifications

    • 13.2.3 Medtronic Plc. Intrasaccular Embolic Coils Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Medtronic Plc. Main Business Overview

    • 13.2.5 Medtronic Plc. Latest Developments

  • 13.3 Stryker Corporation

    • 13.3.1 Stryker Corporation Company Information

    • 13.3.2 Stryker Corporation Intrasaccular Embolic Coils Product Portfolios and Specifications

    • 13.3.3 Stryker Corporation Intrasaccular Embolic Coils Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Stryker Corporation Main Business Overview

    • 13.3.5 Stryker Corporation Latest Developments

  • 13.4 Cook Medical

    • 13.4.1 Cook Medical Company Information

    • 13.4.2 Cook Medical Intrasaccular Embolic Coils Product Portfolios and Specifications

    • 13.4.3 Cook Medical Intrasaccular Embolic Coils Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Cook Medical Main Business Overview

    • 13.4.5 Cook Medical Latest Developments

  • 13.5 dePuySynthes

    • 13.5.1 dePuySynthes Company Information

    • 13.5.2 dePuySynthes Intrasaccular Embolic Coils Product Portfolios and Specifications

    • 13.5.3 dePuySynthes Intrasaccular Embolic Coils Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 dePuySynthes Main Business Overview

    • 13.5.5 dePuySynthes Latest Developments

  • 13.6 Kaneka Pharmaceuticals

    • 13.6.1 Kaneka Pharmaceuticals Company Information

    • 13.6.2 Kaneka Pharmaceuticals Intrasaccular Embolic Coils Product Portfolios and Specifications

    • 13.6.3 Kaneka Pharmaceuticals Intrasaccular Embolic Coils Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Kaneka Pharmaceuticals Main Business Overview

    • 13.6.5 Kaneka Pharmaceuticals Latest Developments

  • 13.7 Penubbra

    • 13.7.1 Penubbra Company Information

    • 13.7.2 Penubbra Intrasaccular Embolic Coils Product Portfolios and Specifications

    • 13.7.3 Penubbra Intrasaccular Embolic Coils Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Penubbra Main Business Overview

    • 13.7.5 Penubbra Latest Developments

  • 13.8 Braile Biomedica

    • 13.8.1 Braile Biomedica Company Information

    • 13.8.2 Braile Biomedica Intrasaccular Embolic Coils Product Portfolios and Specifications

    • 13.8.3 Braile Biomedica Intrasaccular Embolic Coils Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Braile Biomedica Main Business Overview

    • 13.8.5 Braile Biomedica Latest Developments

• 14 Research Findings and Conclusion